← Insider buys
RVNC

Revance Therapeutics, Inc.

CFO, CBO, Secretary Lauren P Silvernail sold $268K of Revance Therapeutics, Inc.

Sold$268,267
$26.83Price
10,000Shares
−17%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Tue, Nov 7. Filed Thu, Nov 9, 2:46 PM ET, during the session. Not investment advice.